相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The NLRP3 inflammasome in acute myocardial infarction
Stefano Toldo et al.
NATURE REVIEWS CARDIOLOGY (2018)
A new lead to NLRP3 inhibition
Mohamed Lamkanfi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders
Hua Jiang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Autophagy and inflammasomes
James Harris et al.
MOLECULAR IMMUNOLOGY (2017)
CLICs-dependent chloride efflux is an essential and proximal upstream event for NLRP3 inflammasome activation
Tiantian Tang et al.
NATURE COMMUNICATIONS (2017)
NLRP3 inflammasome pathways in atherosclerosis
Marta Baldrighi et al.
ATHEROSCLEROSIS (2017)
Interleukin-1β as emerging therapeutic target in hematological malignancies and potentially in their complications
Lorena Arranz et al.
BLOOD REVIEWS (2017)
Salidroside Attenuates Ventilation Induced Lung Injury via SIRT1-Dependent Inhibition of NLRP3 Inflammasome
Yan Wang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Molecular mechanisms regulating NLRP3 inflammasome activation
Eun-Kyeong Jo et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2016)
Sulforaphane inhibits multiple inflammasomes through an Nrf2-independent mechanism
Allison J. Greaney et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
Beta-Blockers: Current State of Knowledge and Perspectives
Magdalena Ogrodowczyk et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2016)
Carvedilol suppresses cartilage matrix destruction
Zhigang Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Carvedilol protects the kidneys of tumor-bearing mice without impairing the biodistribution or the genotoxicity of cisplatin
Maria A. Carvalho Rodrigues et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2016)
Design, Synthesis, and Evaluation of Acrylamide Derivatives as Direct NLRP3 Inflammasome Inhibitors
Mattia Cocco et al.
CHEMMEDCHEM (2016)
SIRT1 inhibits inflammatory response partly through regulation of NLRP3 inflammasome in vascular endothelial cells
Yanxiang Li et al.
MOLECULAR IMMUNOLOGY (2016)
When gout goes to the heart: does gout equal a cardiovascular disease risk factor?
Jasvinder A. Singh
ANNALS OF THE RHEUMATIC DISEASES (2015)
Resveratrol Inhibits NLRP3 Inflammasome Activation by Preserving Mitochondrial Integrity and Augmenting Autophagy
Ya-Ping Chang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2015)
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
Rebecca C. Coll et al.
NATURE MEDICINE (2015)
Inflammasomes: mechanism of action, role in disease, and therapeutics
Haitao Guo et al.
NATURE MEDICINE (2015)
Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives
Ema Ozaki et al.
JOURNAL OF INFLAMMATION RESEARCH (2015)
Unified Polymerization Mechanism for the Assembly of ASC-Dependent Inflammasomes
Alvin Lu et al.
CELL (2014)
Anti-inflammatory therapies for cardiovascular disease
Paul M. Ridker et al.
EUROPEAN HEART JOURNAL (2014)
The Lysosome Rupture-activated TAK1-JNK Pathway Regulates NLRP3 Inflammasome Activation
Masahiro Okada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Activation of Nlrp3 Inflammasomes Enhances Macrophage Lipid-Deposition and Migration: Implication of a Novel Role of Inflammasome in Atherogenesis
Xiang Li et al.
PLOS ONE (2014)
Lipopolysaccharide/adenosine triphosphate-mediated signal transduction in the regulation of NLRP3 protein expression and caspase-1-mediated interleukin-1β secretion
Pei-Chun Liao et al.
INFLAMMATION RESEARCH (2013)
Resveratrol Inhibits Ionising Irradiation-Induced Inflammation in MSCs by Activating SIRT1 and Limiting NLRP-3 Inflammasome Activation
Yue Fu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Carvedilol Decrease IL-1β and TNF-α, Inhibits MMP-2, MMP-9, COX-2, and RANKL Expression, and Up-Regulates OPG in a Rat Model of Periodontitis
Raimundo Fernandes de Araujo Junior et al.
PLOS ONE (2013)
Sensing and reacting to microbes through the inflammasomes
Luigi Franchi et al.
NATURE IMMUNOLOGY (2012)
Carvedilol inhibits Kir2.3 channels by interference with PIP2-channel interaction
Tania Ferrer et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Cutting Edge: Reactive Oxygen Species Inhibitors Block Priming, but Not Activation, of the NLRP3 Inflammasome
Franz Bauernfeind et al.
JOURNAL OF IMMUNOLOGY (2011)
Adenovirus Type 5 Rupture of Lysosomes Leads to Cathepsin B-Dependent Mitochondrial Stress and Production of Reactive Oxygen Species
Kathleen A. McGuire et al.
JOURNAL OF VIROLOGY (2011)
A role for mitochondria in NLRP3 inflammasome activation
Rongbin Zhou et al.
NATURE (2011)
Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome
Kiichi Nakahira et al.
NATURE IMMUNOLOGY (2011)
The inhibition in tumor necrosis factor-alpha-induced attenuation in endothelial thrombomodulin expression by carvedilol is mediated by nuclear factor-kappa B and reactive oxygen species
Pen-Yuan Lin et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2010)
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Peter Duewell et al.
NATURE (2010)
Chemical Modification of Proteins at Cysteine: Opportunities in Chemistry and Biology
Justin M. Chalker et al.
CHEMISTRY-AN ASIAN JOURNAL (2009)
Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression
Franz G. Bauernfeind et al.
JOURNAL OF IMMUNOLOGY (2009)
Sirtuin functions in health and disease
Hiroyasu Yamamoto et al.
MOLECULAR ENDOCRINOLOGY (2007)
Antioxidant activity of carvedilol in cardiovascular disease
Paresh Dandona et al.
JOURNAL OF HYPERTENSION (2007)
Carvedilol, a nonselective beta-blocker, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro
Yuichiro Mizuochi et al.
TRANSLATIONAL RESEARCH (2007)
Gout-associated uric acid crystals activate the NALP3 inflammasome
F Martinon et al.
NATURE (2006)
Carvedilol blocks cardiac KATP and KG but not IK1 channels by acting at the bundle-crossing regions
J Kikuta et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Carvedilol, a new antioxidative β-blocker, blocks in vitro human peripheral blood T cell activation by downregulating NF-κB activity
SP Yang et al.
CARDIOVASCULAR RESEARCH (2003)
Cysteine regulation of protein function - as exemplified by NMDA-receptor modulation
SA Lipton et al.
TRENDS IN NEUROSCIENCES (2002)
分享论文
